United Therapeutics Corporation

US$562.02As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:UTHRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 16.65%
Div yield —
ROE 19.13%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.48
PE TTM 21.18
TSR TTM 26.17%
Mkt cap US$23.94B
ROIC 25.79%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$691
23.02%
(55.05%)
Hold 2|10|9|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
8.37
9.06
9.35
9.83
23.75%
25.77%
16.49%
18.48%
Revenue$B
2.408
2.406
2.533
2.524
13.83%
7.58%
8.03%
1.73%
Peers (US$23.94B)
Cap (US$)
PE
32.26B
13.40x
22.83B
—
Capital
TTM
5Y
10Y
Leveragex
1.442
(0.029)
(0.028)
EBIT/Intx
1.169
0.293
0.223
Own earn%
53.70
(0.99)
8.00
Sh yield%
40.97
64.89
61.33
Owners
Insiders/Inst%
0.77
31.89
Short interest%
2.27
SBC / revenue%
2.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
16–23
$1 testx
0.4
Incr. ROIC%
8